Keywords: AstraZeneca, Financial results, Second-quarter 2012

AstraZeneca sales and operating profit slump in 2nd-qrt 2012

Article | 26 July 2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN this morning reported second-quarter 2012 financial results, showing that revenues fell 18% (at constant exchange rates) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

AstraZeneca

Go to company listing